Cargando…
Effects of Pirfenidone on Idiopathic Pulmonary Fibrosis Progression and Safety: Results of Multicenter Prospective Observational Study
SIMPLE SUMMARY: Idiopathic pulmonary fibrosis (IPF) commonly occurs in men in their 60s and results in replacement of the lungs parenchyma with fibrotic tissue. Usually, with such a diagnosis, patients die within 3–5 years. This disease is relatively rare, with approximately 1 case per 10,000 popula...
Autores principales: | Avdeev, Sergey, Ilkovich, Mikhail, Terpigorev, Stanislav, Moiseev, Sergey, Tyurin, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963853/ https://www.ncbi.nlm.nih.gov/pubmed/36836840 http://dx.doi.org/10.3390/life13020483 |
Ejemplares similares
-
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
por: Takeda, Yoshito, et al.
Publicado: (2014) -
Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011) -
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022) -
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
por: Flaherty, Kevin R., et al.
Publicado: (2018) -
Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
por: Lancaster, Lisa H., et al.
Publicado: (2017)